iCellate searches for collaboration in precision medicine

Submitted by christina on

iCellate is a Swedish company focusing on precision medicine in cancer. Iohn Ryott explains how they address the challenges of finding collaborations with academia and healthcare and contribute to healthcare development.

Read the full interview here (in Swedish) >>